Chiarot, Emiliano
Naimo, Eleonora
Corrado, Alessia
Giannetti, Patrizia
Ros, Immaculada Margarit Y.
Bensi, Giuliano
Funding for this research was provided by:
GlaxoSmithKline
Article History
Received: 21 April 2021
Accepted: 12 October 2021
First Online: 1 November 2021
Competing interests
: This work was sponsored by Novartis Vaccines and Diagnostics Srl, currently owned by the GSK group of companies. All authors have declared the following interests: all authors were employees of Novartis Vaccines at the time of the study. Following the acquisition of Novartis Vaccines by the GSK group of companies in March 2015, all but EN, and AC are now employees of the GSK group of companies. IMR and GB report ownership of GSK shares and/or restricted GSK shares.